Oxygen and Aerosol Delivery Devices Market
完整報告名稱與涵蓋範圍
Oxygen and Aerosol Delivery Devices Market Size, Share & Trends Analysis Report By Products (Oxygen Masks, Nasal Cannulas/ Oxygen Catheter, Oxygen Connecting Tube, Venturi Masks, Non-rebreather Masks, and Other Oxygen Delivery Devices), By Applications, By Region, And By Segment Forecasts, 2024-2031
報告摘要
Across the 2024 to 2031 projection horizon, the worldwide Oxygen and Aerosol Delivery Devices Market is set to register a CAGR of 7.3%.
The Oxygen and Aerosol Delivery Devices sector involves used to treat respiratory and non-respiratory illnesses. This domain has witnessed substantial transformation owing to technological breakthroughs and shifting healthcare dynamics.
The market's upward path is underpinned by escalating healthcare spending, technological evolution, and the escalating focus on personalized and precision-based approaches in healthcare.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold substantial shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and escalating investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Oxygen and Aerosol Delivery Devices Market Snapshot
Chapter 4. Global Oxygen and Aerosol Delivery Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers and Challenges
4.3. Trends
4.4. Industry Analysis – Porter's Five Forces Analysis
4.5. Competitive Landscape & Market Share Analysis
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2019 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product Type:
5.2.1. Oxygen Masks
5.2.2. Nasal Cannulas/ Nasal Oxygen Catheter
5.2.3. Oxygen Connecting Tube
5.2.4. Venturi Masks
5.2.5. Non-rebreather Masks
5.2.6. Reusable Nebuliser
5.2.7. Disposable Nebuliser
5.2.8. Other Oxygen Delivery Devices
Chapter 6. Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application & Market Share, 2019 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Application:
6.2.1. COPD
6.2.2. Asthma
6.2.3. Cystic Fibrosis
6.2.4. Respiratory Distress Syndrome
6.2.5. Pneumonia
6.2.6. Other Diseases
Chapter 7. Oxygen and Aerosol Delivery Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Application, 2019-2031
7.1.2. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by Product, 2019-2031
7.1.3. North America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) estimates and forecasts by country, 2019-2031
7.1.3.1. US
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.2.2. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.2.3. Europe Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2019-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.3.2. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.3.3. Asia Pacific Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, 2019-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.4.2. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.4.3. Latin America Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by country, (US$ Million) 2019-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Application, 2019-2031
7.5.2. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Product, 2019-2031
7.5.3. Middle East & Africa Oxygen and Aerosol Delivery Devices Market revenue (US$ Million) and Volume (No. of Units) by Country, 2019-2031
7.5.3.1. South Africa
7.5.3.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Medline Industries, Inc.
8.2.2. Salter Labs Inc.
8.2.3. Vygon SA
8.2.4. Smiths Medical, Inc.
8.2.5. Medicoplast International GmbH
8.2.6. Purple Surgical
8.2.7. Pennine Healthcare
8.2.8. Besmed Health Business Corp.
8.2.9. Intersurgical Ltd
8.2.10. B. Braun Melsungen AG
8.2.11. ConvaTec Inc.
8.2.12. Flexicare Medical Ltd.
8.2.13. GaleMed Corporation
8.2.14. PARI GmbH
8.2.15. Polymedicure
8.2.16. Teleflex Incorporated
8.2.17. HSINER CO., LTD.
8.2.18. ASID BONZ GmbH
8.2.19. Sumi spółka z ograniczoną odpowiedzialnością sp.k.
8.2.20. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們